J&J Seeks Dismissal Of ERISA Fiduciary Breach Suit Over Drug Benefits
CAMDEN, N.J. — Arguing in part that the sponsor of the self-funded health plans at issue “has every incentive to negotiate the best overall deal,” Johnson and Johnson (J&J) and related...To view the full article, register now.
Already a subscriber? Click here to view full article